17.73
Schlusskurs vom Vortag:
$17.38
Offen:
$17.37
24-Stunden-Volumen:
976.91K
Relative Volume:
0.86
Marktkapitalisierung:
$972.79M
Einnahmen:
$14.34M
Nettoeinkommen (Verlust:
$-199.00M
KGV:
-4.523
EPS:
-3.92
Netto-Cashflow:
$-183.51M
1W Leistung:
+9.04%
1M Leistung:
+28.76%
6M Leistung:
+56.49%
1J Leistung:
+227.73%
Uniqure N V Stock (QURE) Company Profile
Firmenname
Uniqure N V
Sektor
Branche
Telefon
1-339-970-7000
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Vergleichen Sie QURE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
QURE
Uniqure N V
|
17.73 | 933.29M | 14.34M | -199.00M | -183.51M | -3.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-14 | Hochstufung | Mizuho | Neutral → Outperform |
2025-04-01 | Fortgesetzt | Chardan Capital Markets | Buy |
2024-12-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
2024-10-10 | Fortgesetzt | Raymond James | Outperform |
2024-02-29 | Herabstufung | Goldman | Buy → Neutral |
2023-12-19 | Herabstufung | Mizuho | Buy → Neutral |
2022-03-17 | Hochstufung | UBS | Neutral → Buy |
2021-06-15 | Eingeleitet | BTIG Research | Buy |
2021-05-21 | Eingeleitet | UBS | Neutral |
2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
2021-04-01 | Hochstufung | Mizuho | Neutral → Buy |
2021-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
2020-11-24 | Eingeleitet | H.C. Wainwright | Buy |
2020-11-11 | Eingeleitet | Berenberg | Buy |
2020-11-09 | Eingeleitet | Jefferies | Buy |
2020-11-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
2020-08-25 | Eingeleitet | Raymond James | Strong Buy |
2020-07-31 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2020-06-25 | Herabstufung | Mizuho | Buy → Neutral |
2020-06-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2020-06-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2019-12-03 | Eingeleitet | Cowen | Outperform |
2019-12-03 | Eingeleitet | Goldman | Buy |
2019-11-05 | Eingeleitet | Credit Suisse | Outperform |
2019-10-11 | Eingeleitet | Stifel | Buy |
2019-09-25 | Eingeleitet | Bernstein | Outperform |
2019-09-12 | Eingeleitet | Mizuho | Buy |
2019-07-30 | Herabstufung | Guggenheim | Buy → Neutral |
2019-07-08 | Bestätigt | Cantor Fitzgerald | Overweight |
2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
2019-03-29 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Uniqure N V Aktie (QURE) Neueste Nachrichten
Understanding uniQure N.V.’s price movementCEO Change & Weekly Momentum Picks - Newser
Has uniQure N.V. formed a bullish divergence2025 Key Lessons & Fast Gain Stock Tips - Newser
What does recent volatility data suggest for uniQure N.V.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
What indicators show strength in uniQure N.V.2025 Technical Patterns & Safe Capital Preservation Plans - Newser
Ranking uniQure N.V. among high performing stocks via tools2025 Key Lessons & Consistent Growth Equity Picks - Newser
Long term hold vs stop loss in uniQure N.V.Market Performance Report & Verified Short-Term Trading Plans - Newser
Price action breakdown for uniQure N.V.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Can uniQure N.V. rally from current levelsJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
Using economic indicators to assess uniQure N.V. potential2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Is now a turning point for uniQure N.V.Weekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser
Can uniQure N.V. outperform in the next rallyJuly 2025 Update & Long-Term Safe Investment Ideas - khodrobank.com
uniQure N.V. stock chart pattern explained2025 Price Momentum & Consistent Growth Stock Picks - Newser
Using data tools to time your uniQure N.V. exitPortfolio Profit Report & Weekly Stock Performance Updates - Newser
Chart based analysis of uniQure N.V. trendsProduct Launch & AI Powered Market Entry Ideas - Newser
What technical models suggest about uniQure N.V.’s comebackRate Cut & Community Trade Idea Sharing - Newser
Comparing uniQure N.V. in custom built stock radarsAnalyst Downgrade & Long-Term Safe Investment Plans - Newser
Published on: 2025-09-01 20:24:08 - Newser
Technical analysis overview for uniQure N.V. stockPortfolio Return Report & Precise Trade Entry Recommendations - Newser
What’s the outlook for uniQure N.V.’s sectorJuly 2025 Momentum & Verified Stock Trade Ideas - khodrobank.com
Can uniQure N.V. hit a new high this month2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Building trade automation scripts for uniQure N.V.2025 Price Action Summary & Long-Term Growth Plans - Newser
Growth Value: Does uniQure N.V. have pricing power2025 Momentum Check & Short-Term Swing Trade Alerts - khodrobank.com
Should you hold or exit uniQure N.V. nowWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Institutional investors are uniQure N.V.'s (NASDAQ:QURE) biggest bettors and were rewarded after last week's US$53m market cap gain - simplywall.st
Using data filters to optimize entry into uniQure N.V.Analyst Downgrade & Entry and Exit Point Strategies - Newser
uniQure N.V. stock trend outlook and recovery path2025 Price Targets & Smart Swing Trading Techniques - Newser
Tick level data insight on uniQure N.V. volatilityMarket Activity Report & Smart Swing Trading Techniques - Newser
Will a bounce in uniQure N.V. offer an exitTreasury Yields & Advanced Swing Trade Entry Alerts - Newser
How to escape a deep drawdown in uniQure N.V.Market Growth Report & Free Long-Term Investment Growth Plans - Newser
Should you wait for a breakout in uniQure N.V.Weekly Profit Report & AI Based Buy and Sell Signals - Newser
Relative strength of uniQure N.V. in sector analysisWall Street Watch & Long-Term Investment Growth Plans - Newser
Finanzdaten der Uniqure N V-Aktie (QURE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Uniqure N V-Aktie (QURE) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Springhorn Jeremy P. | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
37,694 |
POST LEONARD E | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
29,937 |
Kaye Jack | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
20,439 |
Jacques Rachelle Suzanne | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
28,346 |
Gut Robert | Director |
Jun 20 '25 |
Sale |
14.45 |
3,336 |
48,205 |
56,879 |
Balachandran Madhavan | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
37,697 |
Meek David D. | Director |
Jun 20 '25 |
Sale |
14.45 |
2,112 |
30,518 |
34,190 |
Potts Jeannette | Chief Legal Officer |
Jun 16 '25 |
Sale |
15.14 |
4,670 |
70,704 |
115,073 |
Kapusta Matthew C | CEO, Managing Director |
Mar 04 '25 |
Sale |
10.29 |
28,341 |
291,629 |
651,454 |
Abi-Saab Walid | Chief Medical Officer |
Mar 04 '25 |
Sale |
10.29 |
1,350 |
13,891 |
151,903 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):